[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610884":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":39,"locations":44,"responsibleParty":46,"collaborators":44,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":44,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":44,"maxAge":56,"enrollmentInfo":57,"targetDuration":44,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":44,"overallStatus":67,"whyStopped":44,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":44},{"fullName":5,"class":6},"Hayatabad Medical Complex","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Probiotic group - Intervention","ACTIVE_COMPARATOR","This group will receive intervention",[13],"Drug: Probiotic",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","This group will receive 10% DW",[19],"Drug: 10% dextrose",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Probiotic","All preterm babies \\\u003C34 weeks Gestational age admitted within 24 hrs of life will be eligible for the study. Those full filling inclusion criteria and consenting to participate will be recruited. Consent will be obtained by team not caring for the patient. Each recruited patient will be assigned a case ID number. Based on the Randomization babies will be assigned to either the intervention group or control group.\n\nStudy group: Multistrain probiotic containing a mix of Lactobacillus and Bifidobacterium spp.\n\n* Dose is 1 million international units (0.2ml or 5 drops) OD\n* Started as soon as feed is in initiated",[9],[27],"Multistrain Probiotic",{"type":22,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"10% dextrose","This will receive 10% DW as placebo",[15],[33],"Dextrose water",[35],{"name":36,"affiliation":37,"role":38},"Romisa Romisa, MBBS, FCPS","Hyatabad Medical Complex","PRINCIPAL_INVESTIGATOR",[40],{"name":41,"role":42,"phone":43,"phoneExt":44,"email":45},"Romisa Rehman, MBBS, FCPS","CONTACT","+923219059305",null,"measa_awan@hotmail.com",{"type":47,"investigatorFullName":44,"investigatorTitle":44,"investigatorAffiliation":44,"oldNameTitle":44,"oldOrganization":44},"SPONSOR","100610884","assessing-the-efficacy-of-probiotics-in-prevention-of-nec-in-preterm-babies-100610884",false,"NCT07233382","Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies","Inclusion Criteria:\n\n* Male and female preterm infants with a gestational age less than 35 weeks.\n* All indoor patients and outdoor patients who present within 24hrs of birth\n\nExclusion Criteria:\n\n* • Infants with congenital or developmental gastrointestinal disorders for example omphalocele, malrotation, gastroschisis.\n\n  * Infants with severe sepsis or gastrointestinal bleeding on presentation",true,"ALL","1 Day",{"count":58,"type":59},196,"ESTIMATED","INTERVENTIONAL",[62],"NA","The goal of the study is to check efficacy of probiotics in preventing necrotizing enterocolitis. The main questions would be if the preterm baby developed NEC or not.",[65,66],"NEC","NEC - Necrotizing Enterocolitis","NOT_YET_RECRUITING","2025-11-28",{"date":70,"type":71},"2025-12-05","ACTUAL",{"date":73,"type":59},"2025-12-01",{"date":75,"type":59},"2026-05-30",{"name":5,"class":6}]